Global Adalimumab Injection Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Adalimumab Injection Market Size was estimated at USD 957.00 million in 2023 and is projected to reach USD 1327.08 million by 2029, exhibiting a CAGR of 5.60% during the forecast period.
This report provides a deep insight into the global Adalimumab Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Adalimumab Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Adalimumab Injection market in any manner.
Global Adalimumab Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AbbVie
Amgen
Sandoz
Fresenius Kabi
Biogen
Celltrion
Cadila Pharmaceuticals
Bio-Thera Solutions, Ltd.
Hisun Biopharmaceutical
Innovent Biologics
Mylan
Zydus Group
Boehringer Ingelheim
Jiangsu Chia Tai-Tianqing Pharmaceutical
Shanghai Henlius Biotech
Market Segmentation (by Type)
40mg/0.8ml
20mg/0.4ml
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Adalimumab Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Adalimumab Injection Market Size was estimated at USD 957.00 million in 2023 and is projected to reach USD 1327.08 million by 2029, exhibiting a CAGR of 5.60% during the forecast period.
This report provides a deep insight into the global Adalimumab Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Adalimumab Injection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Adalimumab Injection market in any manner.
Global Adalimumab Injection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AbbVie
Amgen
Sandoz
Fresenius Kabi
Biogen
Celltrion
Cadila Pharmaceuticals
Bio-Thera Solutions, Ltd.
Hisun Biopharmaceutical
Innovent Biologics
Mylan
Zydus Group
Boehringer Ingelheim
Jiangsu Chia Tai-Tianqing Pharmaceutical
Shanghai Henlius Biotech
Market Segmentation (by Type)
40mg/0.8ml
20mg/0.4ml
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Adalimumab Injection Market
- Overview of the regional outlook of the Adalimumab Injection Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Adalimumab Injection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Adalimumab Injection
1.2 Key Market Segments
1.2.1 Adalimumab Injection Segment by Type
1.2.2 Adalimumab Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ADALIMUMAB INJECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Adalimumab Injection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Adalimumab Injection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ADALIMUMAB INJECTION MARKET COMPETITIVE LANDSCAPE
3.1 Global Adalimumab Injection Sales by Manufacturers (2019-2024)
3.2 Global Adalimumab Injection Revenue Market Share by Manufacturers (2019-2024)
3.3 Adalimumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Adalimumab Injection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Adalimumab Injection Sales Sites, Area Served, Product Type
3.6 Adalimumab Injection Market Competitive Situation and Trends
3.6.1 Adalimumab Injection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Adalimumab Injection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ADALIMUMAB INJECTION INDUSTRY CHAIN ANALYSIS
4.1 Adalimumab Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ADALIMUMAB INJECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ADALIMUMAB INJECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adalimumab Injection Sales Market Share by Type (2019-2024)
6.3 Global Adalimumab Injection Market Size Market Share by Type (2019-2024)
6.4 Global Adalimumab Injection Price by Type (2019-2024)
7 ADALIMUMAB INJECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adalimumab Injection Market Sales by Application (2019-2024)
7.3 Global Adalimumab Injection Market Size (M USD) by Application (2019-2024)
7.4 Global Adalimumab Injection Sales Growth Rate by Application (2019-2024)
8 ADALIMUMAB INJECTION MARKET SEGMENTATION BY REGION
8.1 Global Adalimumab Injection Sales by Region
8.1.1 Global Adalimumab Injection Sales by Region
8.1.2 Global Adalimumab Injection Sales Market Share by Region
8.2 North America
8.2.1 North America Adalimumab Injection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Adalimumab Injection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Adalimumab Injection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Adalimumab Injection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Adalimumab Injection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AbbVie
9.1.1 AbbVie Adalimumab Injection Basic Information
9.1.2 AbbVie Adalimumab Injection Product Overview
9.1.3 AbbVie Adalimumab Injection Product Market Performance
9.1.4 AbbVie Business Overview
9.1.5 AbbVie Adalimumab Injection SWOT Analysis
9.1.6 AbbVie Recent Developments
9.2 Amgen
9.2.1 Amgen Adalimumab Injection Basic Information
9.2.2 Amgen Adalimumab Injection Product Overview
9.2.3 Amgen Adalimumab Injection Product Market Performance
9.2.4 Amgen Business Overview
9.2.5 Amgen Adalimumab Injection SWOT Analysis
9.2.6 Amgen Recent Developments
9.3 Sandoz
9.3.1 Sandoz Adalimumab Injection Basic Information
9.3.2 Sandoz Adalimumab Injection Product Overview
9.3.3 Sandoz Adalimumab Injection Product Market Performance
9.3.4 Sandoz Adalimumab Injection SWOT Analysis
9.3.5 Sandoz Business Overview
9.3.6 Sandoz Recent Developments
9.4 Fresenius Kabi
9.4.1 Fresenius Kabi Adalimumab Injection Basic Information
9.4.2 Fresenius Kabi Adalimumab Injection Product Overview
9.4.3 Fresenius Kabi Adalimumab Injection Product Market Performance
9.4.4 Fresenius Kabi Business Overview
9.4.5 Fresenius Kabi Recent Developments
9.5 Biogen
9.5.1 Biogen Adalimumab Injection Basic Information
9.5.2 Biogen Adalimumab Injection Product Overview
9.5.3 Biogen Adalimumab Injection Product Market Performance
9.5.4 Biogen Business Overview
9.5.5 Biogen Recent Developments
9.6 Celltrion
9.6.1 Celltrion Adalimumab Injection Basic Information
9.6.2 Celltrion Adalimumab Injection Product Overview
9.6.3 Celltrion Adalimumab Injection Product Market Performance
9.6.4 Celltrion Business Overview
9.6.5 Celltrion Recent Developments
9.7 Cadila Pharmaceuticals
9.7.1 Cadila Pharmaceuticals Adalimumab Injection Basic Information
9.7.2 Cadila Pharmaceuticals Adalimumab Injection Product Overview
9.7.3 Cadila Pharmaceuticals Adalimumab Injection Product Market Performance
9.7.4 Cadila Pharmaceuticals Business Overview
9.7.5 Cadila Pharmaceuticals Recent Developments
9.8 Bio-Thera Solutions, Ltd.
9.8.1 Bio-Thera Solutions, Ltd. Adalimumab Injection Basic Information
9.8.2 Bio-Thera Solutions, Ltd. Adalimumab Injection Product Overview
9.8.3 Bio-Thera Solutions, Ltd. Adalimumab Injection Product Market Performance
9.8.4 Bio-Thera Solutions, Ltd. Business Overview
9.8.5 Bio-Thera Solutions, Ltd. Recent Developments
9.9 Hisun Biopharmaceutical
9.9.1 Hisun Biopharmaceutical Adalimumab Injection Basic Information
9.9.2 Hisun Biopharmaceutical Adalimumab Injection Product Overview
9.9.3 Hisun Biopharmaceutical Adalimumab Injection Product Market Performance
9.9.4 Hisun Biopharmaceutical Business Overview
9.9.5 Hisun Biopharmaceutical Recent Developments
9.10 Innovent Biologics
9.10.1 Innovent Biologics Adalimumab Injection Basic Information
9.10.2 Innovent Biologics Adalimumab Injection Product Overview
9.10.3 Innovent Biologics Adalimumab Injection Product Market Performance
9.10.4 Innovent Biologics Business Overview
9.10.5 Innovent Biologics Recent Developments
9.11 Mylan
9.11.1 Mylan Adalimumab Injection Basic Information
9.11.2 Mylan Adalimumab Injection Product Overview
9.11.3 Mylan Adalimumab Injection Product Market Performance
9.11.4 Mylan Business Overview
9.11.5 Mylan Recent Developments
9.12 Zydus Group
9.12.1 Zydus Group Adalimumab Injection Basic Information
9.12.2 Zydus Group Adalimumab Injection Product Overview
9.12.3 Zydus Group Adalimumab Injection Product Market Performance
9.12.4 Zydus Group Business Overview
9.12.5 Zydus Group Recent Developments
9.13 Boehringer Ingelheim
9.13.1 Boehringer Ingelheim Adalimumab Injection Basic Information
9.13.2 Boehringer Ingelheim Adalimumab Injection Product Overview
9.13.3 Boehringer Ingelheim Adalimumab Injection Product Market Performance
9.13.4 Boehringer Ingelheim Business Overview
9.13.5 Boehringer Ingelheim Recent Developments
9.14 Jiangsu Chia Tai-Tianqing Pharmaceutical
9.14.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Basic Information
9.14.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Overview
9.14.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Market Performance
9.14.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Business Overview
9.14.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments
9.15 Shanghai Henlius Biotech
9.15.1 Shanghai Henlius Biotech Adalimumab Injection Basic Information
9.15.2 Shanghai Henlius Biotech Adalimumab Injection Product Overview
9.15.3 Shanghai Henlius Biotech Adalimumab Injection Product Market Performance
9.15.4 Shanghai Henlius Biotech Business Overview
9.15.5 Shanghai Henlius Biotech Recent Developments
10 ADALIMUMAB INJECTION MARKET FORECAST BY REGION
10.1 Global Adalimumab Injection Market Size Forecast
10.2 Global Adalimumab Injection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Adalimumab Injection Market Size Forecast by Country
10.2.3 Asia Pacific Adalimumab Injection Market Size Forecast by Region
10.2.4 South America Adalimumab Injection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Adalimumab Injection by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Adalimumab Injection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Adalimumab Injection by Type (2025-2030)
11.1.2 Global Adalimumab Injection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Adalimumab Injection by Type (2025-2030)
11.2 Global Adalimumab Injection Market Forecast by Application (2025-2030)
11.2.1 Global Adalimumab Injection Sales (Kilotons) Forecast by Application
11.2.2 Global Adalimumab Injection Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Adalimumab Injection
1.2 Key Market Segments
1.2.1 Adalimumab Injection Segment by Type
1.2.2 Adalimumab Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ADALIMUMAB INJECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Adalimumab Injection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Adalimumab Injection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ADALIMUMAB INJECTION MARKET COMPETITIVE LANDSCAPE
3.1 Global Adalimumab Injection Sales by Manufacturers (2019-2024)
3.2 Global Adalimumab Injection Revenue Market Share by Manufacturers (2019-2024)
3.3 Adalimumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Adalimumab Injection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Adalimumab Injection Sales Sites, Area Served, Product Type
3.6 Adalimumab Injection Market Competitive Situation and Trends
3.6.1 Adalimumab Injection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Adalimumab Injection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ADALIMUMAB INJECTION INDUSTRY CHAIN ANALYSIS
4.1 Adalimumab Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ADALIMUMAB INJECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ADALIMUMAB INJECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adalimumab Injection Sales Market Share by Type (2019-2024)
6.3 Global Adalimumab Injection Market Size Market Share by Type (2019-2024)
6.4 Global Adalimumab Injection Price by Type (2019-2024)
7 ADALIMUMAB INJECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adalimumab Injection Market Sales by Application (2019-2024)
7.3 Global Adalimumab Injection Market Size (M USD) by Application (2019-2024)
7.4 Global Adalimumab Injection Sales Growth Rate by Application (2019-2024)
8 ADALIMUMAB INJECTION MARKET SEGMENTATION BY REGION
8.1 Global Adalimumab Injection Sales by Region
8.1.1 Global Adalimumab Injection Sales by Region
8.1.2 Global Adalimumab Injection Sales Market Share by Region
8.2 North America
8.2.1 North America Adalimumab Injection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Adalimumab Injection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Adalimumab Injection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Adalimumab Injection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Adalimumab Injection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AbbVie
9.1.1 AbbVie Adalimumab Injection Basic Information
9.1.2 AbbVie Adalimumab Injection Product Overview
9.1.3 AbbVie Adalimumab Injection Product Market Performance
9.1.4 AbbVie Business Overview
9.1.5 AbbVie Adalimumab Injection SWOT Analysis
9.1.6 AbbVie Recent Developments
9.2 Amgen
9.2.1 Amgen Adalimumab Injection Basic Information
9.2.2 Amgen Adalimumab Injection Product Overview
9.2.3 Amgen Adalimumab Injection Product Market Performance
9.2.4 Amgen Business Overview
9.2.5 Amgen Adalimumab Injection SWOT Analysis
9.2.6 Amgen Recent Developments
9.3 Sandoz
9.3.1 Sandoz Adalimumab Injection Basic Information
9.3.2 Sandoz Adalimumab Injection Product Overview
9.3.3 Sandoz Adalimumab Injection Product Market Performance
9.3.4 Sandoz Adalimumab Injection SWOT Analysis
9.3.5 Sandoz Business Overview
9.3.6 Sandoz Recent Developments
9.4 Fresenius Kabi
9.4.1 Fresenius Kabi Adalimumab Injection Basic Information
9.4.2 Fresenius Kabi Adalimumab Injection Product Overview
9.4.3 Fresenius Kabi Adalimumab Injection Product Market Performance
9.4.4 Fresenius Kabi Business Overview
9.4.5 Fresenius Kabi Recent Developments
9.5 Biogen
9.5.1 Biogen Adalimumab Injection Basic Information
9.5.2 Biogen Adalimumab Injection Product Overview
9.5.3 Biogen Adalimumab Injection Product Market Performance
9.5.4 Biogen Business Overview
9.5.5 Biogen Recent Developments
9.6 Celltrion
9.6.1 Celltrion Adalimumab Injection Basic Information
9.6.2 Celltrion Adalimumab Injection Product Overview
9.6.3 Celltrion Adalimumab Injection Product Market Performance
9.6.4 Celltrion Business Overview
9.6.5 Celltrion Recent Developments
9.7 Cadila Pharmaceuticals
9.7.1 Cadila Pharmaceuticals Adalimumab Injection Basic Information
9.7.2 Cadila Pharmaceuticals Adalimumab Injection Product Overview
9.7.3 Cadila Pharmaceuticals Adalimumab Injection Product Market Performance
9.7.4 Cadila Pharmaceuticals Business Overview
9.7.5 Cadila Pharmaceuticals Recent Developments
9.8 Bio-Thera Solutions, Ltd.
9.8.1 Bio-Thera Solutions, Ltd. Adalimumab Injection Basic Information
9.8.2 Bio-Thera Solutions, Ltd. Adalimumab Injection Product Overview
9.8.3 Bio-Thera Solutions, Ltd. Adalimumab Injection Product Market Performance
9.8.4 Bio-Thera Solutions, Ltd. Business Overview
9.8.5 Bio-Thera Solutions, Ltd. Recent Developments
9.9 Hisun Biopharmaceutical
9.9.1 Hisun Biopharmaceutical Adalimumab Injection Basic Information
9.9.2 Hisun Biopharmaceutical Adalimumab Injection Product Overview
9.9.3 Hisun Biopharmaceutical Adalimumab Injection Product Market Performance
9.9.4 Hisun Biopharmaceutical Business Overview
9.9.5 Hisun Biopharmaceutical Recent Developments
9.10 Innovent Biologics
9.10.1 Innovent Biologics Adalimumab Injection Basic Information
9.10.2 Innovent Biologics Adalimumab Injection Product Overview
9.10.3 Innovent Biologics Adalimumab Injection Product Market Performance
9.10.4 Innovent Biologics Business Overview
9.10.5 Innovent Biologics Recent Developments
9.11 Mylan
9.11.1 Mylan Adalimumab Injection Basic Information
9.11.2 Mylan Adalimumab Injection Product Overview
9.11.3 Mylan Adalimumab Injection Product Market Performance
9.11.4 Mylan Business Overview
9.11.5 Mylan Recent Developments
9.12 Zydus Group
9.12.1 Zydus Group Adalimumab Injection Basic Information
9.12.2 Zydus Group Adalimumab Injection Product Overview
9.12.3 Zydus Group Adalimumab Injection Product Market Performance
9.12.4 Zydus Group Business Overview
9.12.5 Zydus Group Recent Developments
9.13 Boehringer Ingelheim
9.13.1 Boehringer Ingelheim Adalimumab Injection Basic Information
9.13.2 Boehringer Ingelheim Adalimumab Injection Product Overview
9.13.3 Boehringer Ingelheim Adalimumab Injection Product Market Performance
9.13.4 Boehringer Ingelheim Business Overview
9.13.5 Boehringer Ingelheim Recent Developments
9.14 Jiangsu Chia Tai-Tianqing Pharmaceutical
9.14.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Basic Information
9.14.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Overview
9.14.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Market Performance
9.14.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Business Overview
9.14.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments
9.15 Shanghai Henlius Biotech
9.15.1 Shanghai Henlius Biotech Adalimumab Injection Basic Information
9.15.2 Shanghai Henlius Biotech Adalimumab Injection Product Overview
9.15.3 Shanghai Henlius Biotech Adalimumab Injection Product Market Performance
9.15.4 Shanghai Henlius Biotech Business Overview
9.15.5 Shanghai Henlius Biotech Recent Developments
10 ADALIMUMAB INJECTION MARKET FORECAST BY REGION
10.1 Global Adalimumab Injection Market Size Forecast
10.2 Global Adalimumab Injection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Adalimumab Injection Market Size Forecast by Country
10.2.3 Asia Pacific Adalimumab Injection Market Size Forecast by Region
10.2.4 South America Adalimumab Injection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Adalimumab Injection by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Adalimumab Injection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Adalimumab Injection by Type (2025-2030)
11.1.2 Global Adalimumab Injection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Adalimumab Injection by Type (2025-2030)
11.2 Global Adalimumab Injection Market Forecast by Application (2025-2030)
11.2.1 Global Adalimumab Injection Sales (Kilotons) Forecast by Application
11.2.2 Global Adalimumab Injection Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Adalimumab Injection Market Size Comparison by Region (M USD)
Table 5. Global Adalimumab Injection Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Adalimumab Injection Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Adalimumab Injection Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Adalimumab Injection Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adalimumab Injection as of 2022)
Table 10. Global Market Adalimumab Injection Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Adalimumab Injection Sales Sites and Area Served
Table 12. Manufacturers Adalimumab Injection Product Type
Table 13. Global Adalimumab Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Adalimumab Injection
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Adalimumab Injection Market Challenges
Table 22. Global Adalimumab Injection Sales by Type (Kilotons)
Table 23. Global Adalimumab Injection Market Size by Type (M USD)
Table 24. Global Adalimumab Injection Sales (Kilotons) by Type (2019-2024)
Table 25. Global Adalimumab Injection Sales Market Share by Type (2019-2024)
Table 26. Global Adalimumab Injection Market Size (M USD) by Type (2019-2024)
Table 27. Global Adalimumab Injection Market Size Share by Type (2019-2024)
Table 28. Global Adalimumab Injection Price (USD/Ton) by Type (2019-2024)
Table 29. Global Adalimumab Injection Sales (Kilotons) by Application
Table 30. Global Adalimumab Injection Market Size by Application
Table 31. Global Adalimumab Injection Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Adalimumab Injection Sales Market Share by Application (2019-2024)
Table 33. Global Adalimumab Injection Sales by Application (2019-2024) & (M USD)
Table 34. Global Adalimumab Injection Market Share by Application (2019-2024)
Table 35. Global Adalimumab Injection Sales Growth Rate by Application (2019-2024)
Table 36. Global Adalimumab Injection Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Adalimumab Injection Sales Market Share by Region (2019-2024)
Table 38. North America Adalimumab Injection Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Adalimumab Injection Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Adalimumab Injection Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Adalimumab Injection Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Adalimumab Injection Sales by Region (2019-2024) & (Kilotons)
Table 43. AbbVie Adalimumab Injection Basic Information
Table 44. AbbVie Adalimumab Injection Product Overview
Table 45. AbbVie Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. AbbVie Business Overview
Table 47. AbbVie Adalimumab Injection SWOT Analysis
Table 48. AbbVie Recent Developments
Table 49. Amgen Adalimumab Injection Basic Information
Table 50. Amgen Adalimumab Injection Product Overview
Table 51. Amgen Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Amgen Business Overview
Table 53. Amgen Adalimumab Injection SWOT Analysis
Table 54. Amgen Recent Developments
Table 55. Sandoz Adalimumab Injection Basic Information
Table 56. Sandoz Adalimumab Injection Product Overview
Table 57. Sandoz Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sandoz Adalimumab Injection SWOT Analysis
Table 59. Sandoz Business Overview
Table 60. Sandoz Recent Developments
Table 61. Fresenius Kabi Adalimumab Injection Basic Information
Table 62. Fresenius Kabi Adalimumab Injection Product Overview
Table 63. Fresenius Kabi Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Fresenius Kabi Business Overview
Table 65. Fresenius Kabi Recent Developments
Table 66. Biogen Adalimumab Injection Basic Information
Table 67. Biogen Adalimumab Injection Product Overview
Table 68. Biogen Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Biogen Business Overview
Table 70. Biogen Recent Developments
Table 71. Celltrion Adalimumab Injection Basic Information
Table 72. Celltrion Adalimumab Injection Product Overview
Table 73. Celltrion Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Celltrion Business Overview
Table 75. Celltrion Recent Developments
Table 76. Cadila Pharmaceuticals Adalimumab Injection Basic Information
Table 77. Cadila Pharmaceuticals Adalimumab Injection Product Overview
Table 78. Cadila Pharmaceuticals Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Cadila Pharmaceuticals Business Overview
Table 80. Cadila Pharmaceuticals Recent Developments
Table 81. Bio-Thera Solutions, Ltd. Adalimumab Injection Basic Information
Table 82. Bio-Thera Solutions, Ltd. Adalimumab Injection Product Overview
Table 83. Bio-Thera Solutions, Ltd. Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bio-Thera Solutions, Ltd. Business Overview
Table 85. Bio-Thera Solutions, Ltd. Recent Developments
Table 86. Hisun Biopharmaceutical Adalimumab Injection Basic Information
Table 87. Hisun Biopharmaceutical Adalimumab Injection Product Overview
Table 88. Hisun Biopharmaceutical Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Hisun Biopharmaceutical Business Overview
Table 90. Hisun Biopharmaceutical Recent Developments
Table 91. Innovent Biologics Adalimumab Injection Basic Information
Table 92. Innovent Biologics Adalimumab Injection Product Overview
Table 93. Innovent Biologics Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Innovent Biologics Business Overview
Table 95. Innovent Biologics Recent Developments
Table 96. Mylan Adalimumab Injection Basic Information
Table 97. Mylan Adalimumab Injection Product Overview
Table 98. Mylan Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Mylan Business Overview
Table 100. Mylan Recent Developments
Table 101. Zydus Group Adalimumab Injection Basic Information
Table 102. Zydus Group Adalimumab Injection Product Overview
Table 103. Zydus Group Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Zydus Group Business Overview
Table 105. Zydus Group Recent Developments
Table 106. Boehringer Ingelheim Adalimumab Injection Basic Information
Table 107. Boehringer Ingelheim Adalimumab Injection Product Overview
Table 108. Boehringer Ingelheim Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Boehringer Ingelheim Business Overview
Table 110. Boehringer Ingelheim Recent Developments
Table 111. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Basic Information
Table 112. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Overview
Table 113. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Jiangsu Chia Tai-Tianqing Pharmaceutical Business Overview
Table 115. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments
Table 116. Shanghai Henlius Biotech Adalimumab Injection Basic Information
Table 117. Shanghai Henlius Biotech Adalimumab Injection Product Overview
Table 118. Shanghai Henlius Biotech Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Shanghai Henlius Biotech Business Overview
Table 120. Shanghai Henlius Biotech Recent Developments
Table 121. Global Adalimumab Injection Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Adalimumab Injection Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Adalimumab Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Adalimumab Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Adalimumab Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Adalimumab Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Adalimumab Injection Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Adalimumab Injection Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Adalimumab Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Adalimumab Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Adalimumab Injection Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Adalimumab Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Adalimumab Injection Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Adalimumab Injection Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Adalimumab Injection Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Adalimumab Injection Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Adalimumab Injection Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Adalimumab Injection Market Size Comparison by Region (M USD)
Table 5. Global Adalimumab Injection Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Adalimumab Injection Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Adalimumab Injection Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Adalimumab Injection Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adalimumab Injection as of 2022)
Table 10. Global Market Adalimumab Injection Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Adalimumab Injection Sales Sites and Area Served
Table 12. Manufacturers Adalimumab Injection Product Type
Table 13. Global Adalimumab Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Adalimumab Injection
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Adalimumab Injection Market Challenges
Table 22. Global Adalimumab Injection Sales by Type (Kilotons)
Table 23. Global Adalimumab Injection Market Size by Type (M USD)
Table 24. Global Adalimumab Injection Sales (Kilotons) by Type (2019-2024)
Table 25. Global Adalimumab Injection Sales Market Share by Type (2019-2024)
Table 26. Global Adalimumab Injection Market Size (M USD) by Type (2019-2024)
Table 27. Global Adalimumab Injection Market Size Share by Type (2019-2024)
Table 28. Global Adalimumab Injection Price (USD/Ton) by Type (2019-2024)
Table 29. Global Adalimumab Injection Sales (Kilotons) by Application
Table 30. Global Adalimumab Injection Market Size by Application
Table 31. Global Adalimumab Injection Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Adalimumab Injection Sales Market Share by Application (2019-2024)
Table 33. Global Adalimumab Injection Sales by Application (2019-2024) & (M USD)
Table 34. Global Adalimumab Injection Market Share by Application (2019-2024)
Table 35. Global Adalimumab Injection Sales Growth Rate by Application (2019-2024)
Table 36. Global Adalimumab Injection Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Adalimumab Injection Sales Market Share by Region (2019-2024)
Table 38. North America Adalimumab Injection Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Adalimumab Injection Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Adalimumab Injection Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Adalimumab Injection Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Adalimumab Injection Sales by Region (2019-2024) & (Kilotons)
Table 43. AbbVie Adalimumab Injection Basic Information
Table 44. AbbVie Adalimumab Injection Product Overview
Table 45. AbbVie Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. AbbVie Business Overview
Table 47. AbbVie Adalimumab Injection SWOT Analysis
Table 48. AbbVie Recent Developments
Table 49. Amgen Adalimumab Injection Basic Information
Table 50. Amgen Adalimumab Injection Product Overview
Table 51. Amgen Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Amgen Business Overview
Table 53. Amgen Adalimumab Injection SWOT Analysis
Table 54. Amgen Recent Developments
Table 55. Sandoz Adalimumab Injection Basic Information
Table 56. Sandoz Adalimumab Injection Product Overview
Table 57. Sandoz Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sandoz Adalimumab Injection SWOT Analysis
Table 59. Sandoz Business Overview
Table 60. Sandoz Recent Developments
Table 61. Fresenius Kabi Adalimumab Injection Basic Information
Table 62. Fresenius Kabi Adalimumab Injection Product Overview
Table 63. Fresenius Kabi Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Fresenius Kabi Business Overview
Table 65. Fresenius Kabi Recent Developments
Table 66. Biogen Adalimumab Injection Basic Information
Table 67. Biogen Adalimumab Injection Product Overview
Table 68. Biogen Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Biogen Business Overview
Table 70. Biogen Recent Developments
Table 71. Celltrion Adalimumab Injection Basic Information
Table 72. Celltrion Adalimumab Injection Product Overview
Table 73. Celltrion Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Celltrion Business Overview
Table 75. Celltrion Recent Developments
Table 76. Cadila Pharmaceuticals Adalimumab Injection Basic Information
Table 77. Cadila Pharmaceuticals Adalimumab Injection Product Overview
Table 78. Cadila Pharmaceuticals Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Cadila Pharmaceuticals Business Overview
Table 80. Cadila Pharmaceuticals Recent Developments
Table 81. Bio-Thera Solutions, Ltd. Adalimumab Injection Basic Information
Table 82. Bio-Thera Solutions, Ltd. Adalimumab Injection Product Overview
Table 83. Bio-Thera Solutions, Ltd. Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bio-Thera Solutions, Ltd. Business Overview
Table 85. Bio-Thera Solutions, Ltd. Recent Developments
Table 86. Hisun Biopharmaceutical Adalimumab Injection Basic Information
Table 87. Hisun Biopharmaceutical Adalimumab Injection Product Overview
Table 88. Hisun Biopharmaceutical Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Hisun Biopharmaceutical Business Overview
Table 90. Hisun Biopharmaceutical Recent Developments
Table 91. Innovent Biologics Adalimumab Injection Basic Information
Table 92. Innovent Biologics Adalimumab Injection Product Overview
Table 93. Innovent Biologics Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Innovent Biologics Business Overview
Table 95. Innovent Biologics Recent Developments
Table 96. Mylan Adalimumab Injection Basic Information
Table 97. Mylan Adalimumab Injection Product Overview
Table 98. Mylan Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Mylan Business Overview
Table 100. Mylan Recent Developments
Table 101. Zydus Group Adalimumab Injection Basic Information
Table 102. Zydus Group Adalimumab Injection Product Overview
Table 103. Zydus Group Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Zydus Group Business Overview
Table 105. Zydus Group Recent Developments
Table 106. Boehringer Ingelheim Adalimumab Injection Basic Information
Table 107. Boehringer Ingelheim Adalimumab Injection Product Overview
Table 108. Boehringer Ingelheim Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Boehringer Ingelheim Business Overview
Table 110. Boehringer Ingelheim Recent Developments
Table 111. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Basic Information
Table 112. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Overview
Table 113. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Jiangsu Chia Tai-Tianqing Pharmaceutical Business Overview
Table 115. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments
Table 116. Shanghai Henlius Biotech Adalimumab Injection Basic Information
Table 117. Shanghai Henlius Biotech Adalimumab Injection Product Overview
Table 118. Shanghai Henlius Biotech Adalimumab Injection Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Shanghai Henlius Biotech Business Overview
Table 120. Shanghai Henlius Biotech Recent Developments
Table 121. Global Adalimumab Injection Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Adalimumab Injection Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Adalimumab Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Adalimumab Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Adalimumab Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Adalimumab Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Adalimumab Injection Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Adalimumab Injection Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Adalimumab Injection Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Adalimumab Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Adalimumab Injection Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Adalimumab Injection Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Adalimumab Injection Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Adalimumab Injection Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Adalimumab Injection Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Adalimumab Injection Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Adalimumab Injection Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Adalimumab Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Adalimumab Injection Market Size (M USD), 2019-2030
Figure 5. Global Adalimumab Injection Market Size (M USD) (2019-2030)
Figure 6. Global Adalimumab Injection Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Adalimumab Injection Market Size by Country (M USD)
Figure 11. Adalimumab Injection Sales Share by Manufacturers in 2023
Figure 12. Global Adalimumab Injection Revenue Share by Manufacturers in 2023
Figure 13. Adalimumab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Adalimumab Injection Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Adalimumab Injection Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Adalimumab Injection Market Share by Type
Figure 18. Sales Market Share of Adalimumab Injection by Type (2019-2024)
Figure 19. Sales Market Share of Adalimumab Injection by Type in 2023
Figure 20. Market Size Share of Adalimumab Injection by Type (2019-2024)
Figure 21. Market Size Market Share of Adalimumab Injection by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Adalimumab Injection Market Share by Application
Figure 24. Global Adalimumab Injection Sales Market Share by Application (2019-2024)
Figure 25. Global Adalimumab Injection Sales Market Share by Application in 2023
Figure 26. Global Adalimumab Injection Market Share by Application (2019-2024)
Figure 27. Global Adalimumab Injection Market Share by Application in 2023
Figure 28. Global Adalimumab Injection Sales Growth Rate by Application (2019-2024)
Figure 29. Global Adalimumab Injection Sales Market Share by Region (2019-2024)
Figure 30. North America Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Adalimumab Injection Sales Market Share by Country in 2023
Figure 32. U.S. Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Adalimumab Injection Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Adalimumab Injection Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Adalimumab Injection Sales Market Share by Country in 2023
Figure 37. Germany Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Adalimumab Injection Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Adalimumab Injection Sales Market Share by Region in 2023
Figure 44. China Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Adalimumab Injection Sales and Growth Rate (Kilotons)
Figure 50. South America Adalimumab Injection Sales Market Share by Country in 2023
Figure 51. Brazil Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Adalimumab Injection Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Adalimumab Injection Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Adalimumab Injection Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Adalimumab Injection Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Adalimumab Injection Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Adalimumab Injection Market Share Forecast by Type (2025-2030)
Figure 65. Global Adalimumab Injection Sales Forecast by Application (2025-2030)
Figure 66. Global Adalimumab Injection Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Adalimumab Injection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Adalimumab Injection Market Size (M USD), 2019-2030
Figure 5. Global Adalimumab Injection Market Size (M USD) (2019-2030)
Figure 6. Global Adalimumab Injection Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Adalimumab Injection Market Size by Country (M USD)
Figure 11. Adalimumab Injection Sales Share by Manufacturers in 2023
Figure 12. Global Adalimumab Injection Revenue Share by Manufacturers in 2023
Figure 13. Adalimumab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Adalimumab Injection Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Adalimumab Injection Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Adalimumab Injection Market Share by Type
Figure 18. Sales Market Share of Adalimumab Injection by Type (2019-2024)
Figure 19. Sales Market Share of Adalimumab Injection by Type in 2023
Figure 20. Market Size Share of Adalimumab Injection by Type (2019-2024)
Figure 21. Market Size Market Share of Adalimumab Injection by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Adalimumab Injection Market Share by Application
Figure 24. Global Adalimumab Injection Sales Market Share by Application (2019-2024)
Figure 25. Global Adalimumab Injection Sales Market Share by Application in 2023
Figure 26. Global Adalimumab Injection Market Share by Application (2019-2024)
Figure 27. Global Adalimumab Injection Market Share by Application in 2023
Figure 28. Global Adalimumab Injection Sales Growth Rate by Application (2019-2024)
Figure 29. Global Adalimumab Injection Sales Market Share by Region (2019-2024)
Figure 30. North America Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Adalimumab Injection Sales Market Share by Country in 2023
Figure 32. U.S. Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Adalimumab Injection Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Adalimumab Injection Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Adalimumab Injection Sales Market Share by Country in 2023
Figure 37. Germany Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Adalimumab Injection Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Adalimumab Injection Sales Market Share by Region in 2023
Figure 44. China Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Adalimumab Injection Sales and Growth Rate (Kilotons)
Figure 50. South America Adalimumab Injection Sales Market Share by Country in 2023
Figure 51. Brazil Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Adalimumab Injection Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Adalimumab Injection Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Adalimumab Injection Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Adalimumab Injection Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Adalimumab Injection Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Adalimumab Injection Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Adalimumab Injection Market Share Forecast by Type (2025-2030)
Figure 65. Global Adalimumab Injection Sales Forecast by Application (2025-2030)
Figure 66. Global Adalimumab Injection Market Share Forecast by Application (2025-2030)
